Sunday 17 May 2020
Due to the current Covid-19 outbreak most events for 2020 have been postponed or cancelled. myNEO will attend job fairs and participate in the fol…
read more
Wednesday 4 November 2020
Ghent, Belgium, 4 November 2020 – myNEO, a developer of personalised therapeutics using the patient’s tumour-specific alterations, today announced th…
Monday 12 October 2020
myNEO has been selected as one of the five laureates for Belgian scale-up of the year (entrepreneurs on their way to an international breaktrough). …
Monday 7 September 2020
Cedric Bogaert will present the myNEO technology this week at the MedInvest – AI, Big Data and Digital Health conference. He will explain how AI can …
Monday 31 August 2020
myNEO recently affiliated with Amazon via the Amazon AWS activate program, that allows rapidly growing companies to further expand their MVP. This…
Thursday 2 July 2020
myNEO announces that promising Covid-19 peptides have been identified which will undergo further preclinical testing. By making smart use of existing…
Monday 18 May 2020
myNEO and eTheRNA announce a research programme to investigate a promising long non-coding RNA as a source of immunogenic targets for therapeutic use…
Monday 11 May 2020
myNEO collaborates with VUB-LMCT to develop high-throughput assays for immunogenicity validation of predicted SARS-CoV-2 epitopes The aim of the p…
Monday 4 May 2020
Over the last month, we’ve welcomed both Willem Stock, as a bioinformatician, Christophe Van Huffel, as busdev manager, and Bert Coessens, as technol…
Monday 27 April 2020
Despite the Covid-19 crisis, myNEO has been fully operational and has been focusing on the preparation for the clinical trial of Persomed later this …